Название продукции:4-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

IUPAC Name:4-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

CAS:111661-47-3
Молекулярная формула:C10H14ClN
Чистота:97%
Номер в каталоге:CM130681
Молекулярная масса:183.68

Упаковочная единица Доступно для заказа Цена ($) Количество
CM130681-25g in stock ŸȖdždž

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:111661-47-3
Молекулярная формула:C10H14ClN
Точка плавления:-
Smiles-код:CC1CNCC2=C1C=CC=C2.[H]Cl
Плотность:
Номер в каталоге:CM130681
Молекулярная масса:183.68
Точка кипения:
Номер Mdl:MFCD11501478
Хранение:Store at 2-8°C.

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Product Other Information

Product Overview 4-Methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride (4-MTHIQ-HCl) is a synthetic compound that has been studied for its potential applications in scientific research. 4-MTHIQ-HCl is a derivative of the alkaloid isoquinoline and is known for its unique pharmacological properties. 
Physical Properties This compound is not water-soluble and must be dissolved in a suitable solvent prior to use. Additionally, it has a low solubility in aqueous solutions, which can limit its use in certain experiments.
Chemical Properties This compound is relatively easy to synthesize and is readily available. Additionally, it is stable and can be stored for long periods of time. 
Synthesis and Application It has been used in studies of its pharmacological properties, including its effects on the central nervous system, cardiovascular system, and immune system. This compound has also been used to study the effects of drugs on various physiological processes. Additionally, 4-Methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride has been used in studies of its potential therapeutic applications, such as in the treatment of depression and anxiety.
Future Directions Further research is needed to better understand its mechanism of action and to explore its potential therapeutic applications. Additionally, further studies are needed to explore its potential use in the treatment of various diseases, such as depression and anxiety. Additionally, research is needed to further explore its biochemical and physiological effects, as well as its potential interactions with other drugs. Finally, further research is needed to explore its potential use in other laboratory experiments, such as in the study of cell signaling pathways.